Penumbra, Inc. (PEN) compared with its closest peers (MDLN, WST, SOLV, BAX, GMED): P/E 87.5 vs industry 32.9. Peer set by Business model: Medical Devices / Life Science Tools; 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Medline Inc. (MDLN) | $28.16B | 29.8 |
| West Pharmaceutical Services, Inc. (WST) | $25.00B | 43.7 |
| Solventum Corporation (SOLV) | $15.35B | 10.7 |
| Baxter International Inc. (BAX) | $13.65B | -10.2 |
| Globus Medical, Inc. (GMED) | $11.51B | 21.5 |
| Glaukos Corporation (GKOS) | $10.89B | -34.4 |
| Insulet Corporation (PODD) | $10.17B | 33.6 |
| Teleflex Incorporated (TFX) | $5.98B | -6.0 |
| MiniMed Group, Inc. (MMED) | $5.67B | — |
| Merit Medical Systems, Inc. (MMSI) | $5.39B | 36.3 |
| Stock P/E | 87.5 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Medical Equipment) | 32.9 |
| vs Sector | 305.1% |
| vs Industry | 166.1% |
PEN overview · PEN earnings · PEN financials · PEN KPIs · PEN investor relations · PEN ownership · PEN filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.